The molecular enzymology of cytochromes P450 of biotechnological and medical interest

1

[1]  C. Serhan,et al.  Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. , 2001, The Journal of clinical investigation.

[2]  M. Sutcliffe,et al.  Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity. , 1998, The Biochemical journal.

[3]  John H. White,et al.  Analysis of the domain properties of the novel cytochrome P450 RhF , 2005, FEBS letters.

[4]  G. Babcock,et al.  Insights into heme structure from Soret excitation Raman spectroscopy. , 1981, Biochemistry.

[5]  M. Waterman,et al.  Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology Published, JLR Papers in Press, August 16, 2004. DOI 10.1194/jlr.M400239-JLR200 , 2004, Journal of Lipid Research.

[6]  I. P. Kanaeva,et al.  Protein-protein interactions in microsomal cytochrome P-450 isozyme LM2 and their effect on substrate binding. , 1989, European journal of biochemistry.

[7]  E. Dalmasso,et al.  Estriol bound and ligand-free structures of sterol 14alpha-demethylase. , 2004, Structure.

[8]  Hames,et al.  Instant notes in biochemistry , 2000, Annales de biologie clinique.

[9]  Jonathan P. Clark,et al.  4-Cyanopyridine, a Versatile Spectroscopic Probe for Cytochrome P450 BM3* , 2004, Journal of Biological Chemistry.

[10]  C. Hutchinson,et al.  Purification and reconstitution of the electron transport components for 6-deoxyerythronolide B hydroxylase, a cytochrome P-450 enzyme of macrolide antibiotic (erythromycin) biosynthesis , 1988, Journal of bacteriology.

[11]  N. Scrutton,et al.  Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding. , 2002, Biochemistry.

[12]  F. Guengerich.  Enzymatic oxidation of xenobiotic chemicals. , 1990, Critical reviews in biochemistry and molecular biology.

[13]  A. Vaz,et al.  Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. , 2001, Biochemical pharmacology.

[14]  O. Gotoh,et al.  Sterol 14-demethylase P450 (P45014DM*) is one of the most ancient and conserved P450 species. , 1996, Journal of biochemistry.

[15]  F. Guengerich.  Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. , 2003, Archives of biochemistry and biophysics.

[16]  E. Rubin,et al.  Comprehensive identification of conditionally essential genes in mycobacteria , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Munro,et al.  Determination of the redox properties of human NADPH-cytochrome P450 reductase. , 2001, Biochemistry.

[18]  R. Obach.  Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[19]  T. Poulos,et al.  Substrate recognition sites in 14alpha-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51. , 2001, Journal of inorganic biochemistry.

[20]  L. Wienkers,et al.  In vitro metabolism of clindamycin in human liver and intestinal microsomes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[21]  K. Straub,et al.  Iron metabolism in anoxic environments at near neutral pH. , 2001, FEMS microbiology ecology.

[22]  P. Ortiz de Montellano,et al.  Rescue of His-42 → Ala Horseradish Peroxidase by a Phe-41 → His Mutation , 1996, The Journal of Biological Chemistry.

[23]  F. Guengerich,et al.  The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine is catalyzed by human cytochrome P450 3A enzymes. , 1995, Chemical research in toxicology.

[24]  N. Scrutton,et al.  Switching Pyridine Nucleotide Specificity in P450 BM3 , 2005, Journal of Biological Chemistry.

[25]  S. Sligar,et al.  Coupling of spin, substrate, and redox equilibria in cytochrome P450. , 1976, Biochemistry.

[26]  M K Johnson,et al.  Iron-sulfur proteins: new roles for old clusters. , 1998, Current opinion in chemical biology.

[27]  I. Yamamoto,et al.  Major cytochrome P450 enzymes responsible for microsomal aldehyde oxygenation of 11-oxo-Delta8-tetrahydrocannabinol and 9-anthraldehyde in human liver. , 2002, Drug metabolism and pharmacokinetics.

[28]  G. Schneider,et al.  Siroheme- and [Fe4-S4]-dependent NirA from Mycobacterium tuberculosis Is a Sulfite Reductase with a Covalent Cys-Tyr Bond in the Active Site* , 2005, Journal of Biological Chemistry.

[29]  H. Hori,et al.  Putidaredoxin-cytochrome P450cam interaction. , 2001, Journal of inorganic biochemistry.

[30]  P. Lee-Robichaud,et al.  Lysine mutagenesis identifies cationic charges of human CYP17 that interact with cytochrome b5 to promote male sex-hormone biosynthesis. , 1999, The Biochemical journal.

[31]  S. Kelly,et al.  Molecular basis of resistance to azole antifungals. , 2002, Trends in molecular medicine.

[32]  S. Ragsdale,et al.  The roles of coenzyme A in the pyruvate:ferredoxin oxidoreductase reaction mechanism: rate enhancement of electron transfer from a radical intermediate to an iron-sulfur cluster. , 2002, Biochemistry.

[33]  F. Guengerich.  Reactions and significance of cytochrome P-450 enzymes. , 1991, The Journal of biological chemistry.

[34]  D. Hamdane,et al.  Oxygen activation by cytochrome P450 monooxygenase , 2008, Photosynthesis Research.

[35]  S. Sligar,et al.  A thermodynamic model of regulation: modulation of redox equilibria in camphor monoxygenase. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Sagami,et al.  Distal site and surface mutations of cytochrome P450 1A2 markedly enhance dehalogenation of chlorinated hydrocarbons. , 1997, Archives of biochemistry and biophysics.

[37]  C. C. Correll,et al.  Structure and mechanism of the iron‐sulfur flavoprotein phthalate dioxygenase reductase , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  H. Shoun,et al.  Denitrification by the fungus Fusarium oxysporum and involvement of cytochrome P-450 in the respiratory nitrite reduction. , 1991, The Journal of biological chemistry.

[39]  S. Horinouchi,et al.  Cloning and nucleotide sequence of a bacterial cytochrome P-450VD25 gene encoding vitamin D-3 25-hydroxylase. , 1994, Biochimica et biophysica acta.

[40]  V. Belle,et al.  EPR spectroscopy: a powerful technique for the structural and functional investigation of metalloproteins. , 1999, Biospectroscopy.

[41]  H. Shoun,et al.  Soluble, nitrate/nitrite‐inducible cytochrome P‐450 of the fungus, Fusarium oxysporum , 1989, FEBS letters.

[42]  H. Dailey,et al.  Evidence That the Fourth Ligand to the [2Fe-2S] Cluster in Animal Ferrochelatase Is a Cysteine , 1998, The Journal of Biological Chemistry.

[43]  J. Peterson,et al.  Active-site analysis of ferric P450 enzymes: hydrogen-bonding effects on the circular dichroism spectra. , 1995, Biochemical and biophysical research communications.

[44]  J Berendzen,et al.  The catalytic pathway of cytochrome p450cam at atomic resolution. , 2000, Science.

[45]  V. Coghlan,et al.  Electrostatic interactions stabilizing ferredoxin electron transfer complexes. Disruption by "conservative" mutations. , 1992, The Journal of biological chemistry.

[46]  A. Hooper,et al.  Cytochrome P460 of Nitrosomonas europaea. Formation of the heme-lysine cross-link in a heterologous host and mutagenic conversion to a non-cross-linked cytochrome c'. , 2003, European journal of biochemistry.

[47]  T. Poulos,et al.  Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Raag,et al.  Crystal structure of the carbon monoxide-substrate-cytochrome P-450CAM ternary complex. , 1989, Biochemistry.

[49]  P. D. de Montellano,et al.  Horseradish Peroxidase His-42 → Ala, His-42 → Val, and Phe-41 → Ala Mutants , 1995, The Journal of Biological Chemistry.

[50]  A. Burlingame,et al.  Cytochrome P450cin (CYP176A), Isolation, Expression, and Characterization* , 2002, The Journal of Biological Chemistry.

[51]  M. Brunori,et al.  Binding of NO and CO to the d(1) Heme of cd(1) nitrite reductase from Pseudomonas aeruginosa. , 2001, Biochemistry.

[52]  O. H. Lowry,et al.  The fluorometric measurement of the nucleotides of riboflavin and their concentration in tissues. , 1949, The Journal of biological chemistry.

[53]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[54]  M. Sutcliffe,et al.  Thermodynamic and biophysical characterization of cytochrome P450 BioI from Bacillus subtilis. , 2004, Biochemistry.

[55]  M. Waterman,et al.  Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  K. M. Popov,et al.  Expression and Kinetic Characterization of Recombinant Human Stomach Alcohol Dehydrogenase , 1995, The Journal of Biological Chemistry.

[57]  T. Poulos,et al.  Crystal structure of putidaredoxin, the [2Fe-2S] component of the P450cam monooxygenase system from Pseudomonas putida. , 2003, Journal of molecular biology.

[58]  J. S. Miles,et al.  Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization. , 1992, The Biochemical journal.

[59]  Ilme Schlichting,et al.  Structure and chemistry of cytochrome P450. , 2005, Chemical reviews.

[60]  T. Ost,et al.  Rational re‐design of the substrate binding site of flavocytochrome P450 BM3 , 2000, FEBS letters.

[61]  B. Møller,et al.  Cytochromes P-450 from cassava (Manihot esculenta Crantz) catalyzing the first steps in the biosynthesis of the cyanogenic glucosides linamarin and lotaustralin. Cloning, functional expression in Pichia pastoris, and substrate specificity of the isolated recombinant enzymes. , 2000, The Journal of biological chemistry.

[62]  J. Rush,et al.  Mössbauer spectra of photosystem-I-reaction centres from the blue-green alga Chlorogloea fritschii. , 1979, The Biochemical journal.

[63]  D. Goldberg,et al.  Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[64]  I. Roots,et al.  Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membrane. , 2002, European journal of biochemistry.

[65]  Gurdyal S Besra,et al.  The methyl-branched fortifications of Mycobacterium tuberculosis. , 2002, Chemistry & biology.

[66]  Malcolm D. Walkinshaw,et al.  Atomic Structure of Mycobacterium tuberculosis CYP121 to 1.06 Å Reveals Novel Features of Cytochrome P450* , 2003, The Journal of Biological Chemistry.

[67]  T. Tsuchido,et al.  Purification of Cytochrome P450 and Ferredoxin, Involved in Bisphenol A Degradation, from Sphingomonas sp. Strain AO1 , 2005, Applied and Environmental Microbiology.

[68]  M. Mergeay,et al.  Global analysis of the Ralstonia metallidurans proteome: Prelude for the large‐scale study of heavy metal response , 2004, Proteomics.

[69]  D. Arciero,et al.  Hydroxylamine oxidoreductase from Nitrosomonas europaea is a multimer of an octa-heme subunit. , 1993, The Journal of biological chemistry.

[70]  Farahnaz Movahedzadeh,et al.  What do microarrays really tell us about M. tuberculosis? , 2004, Trends in microbiology.

[71]  I. Schlichting,et al.  Structural aspects of ligand binding to and electron transfer in bacterial and fungal P450s. , 2004, Annual review of biochemistry.

[72]  E. Kannenberg,et al.  The occurrence of hopanoid lipids in Bradyrhizobium bacteria , 1995 .

[73]  L G WHITBY,et al.  A new method for preparing flavin-adenine dinucleotide. , 1953, The Biochemical journal.

[74]  D. Ballou,et al.  Purification and characterization of phthalate oxygenase and phthalate oxygenase reductase from Pseudomonas cepacia. , 1987, The Journal of biological chemistry.

[75]  O. Gotoh,et al.  CYP51-like gene of Mycobacterium tuberculosis actually encodes a P450 similar to eukaryotic CYP51. , 1998, Journal of biochemistry.

[76]  F. Arnold,et al.  Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation , 1999, Nature.

[77]  P. Ortiz de Montellano,et al.  CYP119 plus a Sulfolobus tokodaii strain 7 ferredoxin and 2-oxoacid:ferredoxin oxidoreductase constitute a high-temperature cytochrome P450 catalytic system. , 2002, Journal of the American Chemical Society.

[78]  C. Wolf,et al.  Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[79]  P. Lammers,et al.  Alkane-induced expression, substrate binding profile, and immunolocalization of a cytochrome P450 encoded on the nifD excision element of Anabaena 7120 , 2005, BMC Microbiology.

[80]  H. Ogura,et al.  Functional modulation of a peroxygenase cytochrome P450: novel insight into the mechanisms of peroxygenase and peroxidase enzymes , 2002, FEBS letters.

[81]  N. C. Price,et al.  Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis. , 2002, Journal of inorganic biochemistry.

[82]  C. C. Correll,et al.  Phthalate dioxygenase reductase: a modular structure for electron transfer from pyridine nucleotides to [2Fe-2S]. , 1992, Science.

[83]  A. Munro,et al.  Expression, purification and characterisation of a Bacillus subtilis ferredoxin: a potential electron transfer donor to cytochrome P450 BioI. , 2003, Journal of inorganic biochemistry.

[84]  G. Weber,et al.  Fluorescence of riboflavin and flavin-adenine dinucleotide. , 1950, The Biochemical journal.

[85]  G. Besra,et al.  The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. , 2004, Tuberculosis.

[86]  P. Ortiz de Montellano,et al.  Intermolecular interactions in the AhpC/AhpD antioxidant defense system of Mycobacterium tuberculosis. , 2004, Archives of biochemistry and biophysics.

[87]  P. D. de Montellano,et al.  Horseradish Peroxidase Mutants That Autocatalytically Modify Their Prosthetic Heme Group , 2004, Journal of Biological Chemistry.

[88]  W. Whelan,et al.  The mechanism of carbohydrase action. 5. Action of human salivary alpha-amylase on amylopectin and glycogen. , 1960, The Biochemical journal.

[89]  F. Guengerich,et al.  Kinetic Analysis of Oxidation of Coumarins by Human Cytochrome P450 2A6* , 2005, Journal of Biological Chemistry.

[90]  Benjamin A. Neely,et al.  The 1.92-Å Structure of Streptomyces coelicolor A3(2) CYP154C1 , 2003, The Journal of Biological Chemistry.

[91]  Min Zhang,et al.  Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. , 2003, Journal of medicinal chemistry.

[92]  M. J. Coon.  Enzyme Ingenuity in Biological Oxidations: a Trail Leading to Cytochrome P450 , 2002, The Journal of Biological Chemistry.

[93]  R. Santus,et al.  One-electron photoreduction of bacterial cytochrome P-450 by ultraviolet light. I. Steady-state irradiations. , 2005, European journal of biochemistry.

[94]  R. Estabrook,et al.  Cytochrome P450 and the arachidonate cascade 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  J. Peterson,et al.  The kinetics of reduction of cytochrome P-450cam by reduced putidaredoxin. , 1981, The Journal of biological chemistry.

[96]  Tsutomu Shimada,et al.  Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. , 2006, Drug metabolism and pharmacokinetics.

[97]  M. Joyce,et al.  A Single Mutation in Cytochrome P450 BM3 Induces the Conformational Rearrangement Seen upon Substrate Binding in the Wild-type Enzyme* , 2004, Journal of Biological Chemistry.

[98]  H. Strobel,et al.  Denaturation of cytochrome P450 2B1 by guanidine hydrochloride and urea: evidence for a metastable intermediate state of the active site. , 1995, Biochemistry.

[99]  P. Brennan,et al.  Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. , 2001, Glycobiology.

[100]  P. Parte,et al.  OXIDATION OF TAMOXIFEN BY HUMAN FLAVIN-CONTAINING MONOOXYGENASE (FMO) 1 AND FMO3 TO TAMOXIFEN-N-OXIDE AND ITS NOVEL REDUCTION BACK TO TAMOXIFEN BY HUMAN CYTOCHROMES P450 AND HEMOGLOBIN , 2005, Drug Metabolism and Disposition.

[101]  S. Davis,et al.  Minireview: Aromatase and the Regulation of Estrogen Biosynthesis-Some New Perspectives. , 2001, Endocrinology.

[102]  P. Hildebrandt,et al.  Resonance Raman study on the structure of the active sites of microsomal cytochrome P-450 isozymes LM2 and LM4. , 1989, European journal of biochemistry.

[103]  A. Thomson,et al.  Magnetic Circular Dichroism of Hemoproteins , 1991 .

[104]  R. Obach,et al.  SERTRALINE IS METABOLIZED BY MULTIPLE CYTOCHROME P450 ENZYMES, MONOAMINE OXIDASES, AND GLUCURONYL TRANSFERASES IN HUMAN: AN IN VITRO STUDY , 2005, Drug Metabolism and Disposition.

[105]  N. Tuteja,et al.  Unraveling DNA helicases. Motif, structure, mechanism and function. , 2004, European journal of biochemistry.

[106]  D. Shelver,et al.  Probing the heme axial ligation in the CO-sensing CooA protein with magnetic circular dichroism spectroscopy. , 1999, Biochemistry.

[107]  K. R. Marshall,et al.  P450 BM3: the very model of a modern flavocytochrome. , 2002, Trends in biochemical sciences.

[108]  Nigel S. Scrutton,et al.  Redesign of the coenzyme specificity of a dehydrogenase by protein engineering , 1990, Nature.

[109]  Soojay Banerjee,et al.  The effect of denaturants on protein structure , 1997, Protein science : a publication of the Protein Society.

[110]  S. Cole,et al.  Comparative genomics of the leprosy and tubercle bacilli. , 2000, Research in microbiology.

[111]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. , 1993, DNA and cell biology.

[112]  N. Scrutton,et al.  Electron transfer from flavin to iron in the Pseudomonas oleovorans rubredoxin reductase-rubredoxin electron transfer complex. , 1998, Biochemistry.

[113]  N. C. Price,et al.  The use of circular dichroism in the investigation of protein structure and function. , 2000, Current protein & peptide science.

[114]  M. Waterman,et al.  Structural requirements for substrate recognition of Mycobacterium tuberculosis 14 alpha-demethylase: implications for sterol biosynthesis. , 2001, Journal of lipid research.

[115]  C. Wolf,et al.  Engineering of a functional human NADH-dependent cytochrome P450 system. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[116]  Yi Lu,et al.  Neutral thiol as a proximal ligand to ferrous heme iron: Implications for heme proteins that lose cysteine thiolate ligation on reduction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[117]  P. Dutton.  Redox potentiometry: determination of midpoint potentials of oxidation-reduction components of biological electron-transfer systems. , 1978, Methods in enzymology.

[118]  Christopher C. Moser,et al.  Natural engineering principles of electron tunnelling in biological oxidation–reduction , 1999, Nature.

[119]  R. Bernhardt,et al.  Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.

[120]  G. Chumanov,et al.  Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3. , 1998, Biochemistry.

[121]  Frances H Arnold,et al.  Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. , 2003, Journal of the American Chemical Society.

[122]  M Mergeay,et al.  Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend. , 2001, International journal of systematic and evolutionary microbiology.

[123]  J. Deisenhofer,et al.  Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[124]  T. Poulos,et al.  The Domain Architecture of Cytochrome P450BM-3* , 1997, The Journal of Biological Chemistry.

[125]  O. Ristau,et al.  Quantitative analysis of the spin equilibrium of cytochrome P-450 LM-2 fraction from rabbit liver microsomes. , 1978, Biochimica et biophysica acta.

[126]  Fatty acid-induced alteration of the porphyrin macrocycle of cytochrome P450 BM3. , 1998 .

[127]  A. Thomson,et al.  Assignment of the axial ligands of ferric ion in low-spin hemoproteins by near-infrared magnetic circular dichroism and electron paramagnetic resonance spectroscopy , 1990 .

[128]  J. Pieters,et al.  Essential role for cholesterol in entry of mycobacteria into macrophages. , 2000, Science.

[129]  N. C. Price,et al.  Structural and enzymological analysis of the interaction of isolated domains of cytochrome P‐450 BM3 , 1994, FEBS letters.

[130]  M. Ikeda-Saito,et al.  Identification of Nitric Oxide Synthase as a Thiolate-ligated Heme Protein Using Magnetic Circular Dichroism Spectroscopy , 1995, The Journal of Biological Chemistry.

[131]  A. Munro,et al.  Resonance Raman scattering of cytochrome P450 BM3 and effect of imidazole inhibitors. , 2003, Biopolymers.

[132]  I. C. Gunsalus,et al.  Bacterial P-450cam methylene monooxygenase components: cytochrome m, putidaredoxin, and putidaredoxin reductase. , 1978, Methods in enzymology.

[133]  M. Klingenberg.  Pigments of rat liver microsomes. , 1958, Archives of biochemistry and biophysics.

[134]  B. Trumpower,et al.  Simultaneous determination of hemes a, b, and c from pyridine hemochrome spectra. , 1987, Analytical biochemistry.

[135]  Sam-Yong Park,et al.  A Positively Charged Cluster Formed in the Heme-distal Pocket of Cytochrome P450nor Is Essential for Interaction with NADH* , 2001, The Journal of Biological Chemistry.

[136]  A. Proudfoot,et al.  On the relationship between oxidation-reduction potential and biological activity in cytochrome c analogues. Results from four novel two-fragment complexes. , 1987, The Biochemical journal.

[137]  R. Santus,et al.  One-electron photoreduction of bacterial cytochrome P-450 by ultraviolet light. II. A study using laser flash photolysis of the dynamics of the reduction of bacterial cytochrome P-450 in the presence of carbon monoxide. The role of the protein conformation. , 2005, European journal of biochemistry.

[138]  K. Hatano,et al.  Cytochrome P-450 55A1 (P-450dNIR) acts as nitric oxide reductase employing NADH as the direct electron donor. , 1993, The Journal of biological chemistry.

[139]  D. Kelly,et al.  Plant sterol 14 alpha-demethylase affinity for azole fungicides. , 2001, Biochemical and biophysical research communications.

[140]  M. Waterman,et al.  CYP51 from Trypanosoma brucei is obtusifoliol-specific. , 2004, Biochemistry.

[141]  D. Nies,et al.  Efflux-mediated heavy metal resistance in prokaryotes. , 2003, FEMS microbiology reviews.

[142]  P. McDonagh,et al.  Crystal structure of the FMN‐binding domain of human cytochrome P450 reductase at 1.93 Å resolution , 1999, Protein science : a publication of the Protein Society.

[143]  T. Tephly,et al.  The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[144]  U. Liebl,et al.  Electron transfer between hemes in mammalian cytochrome c oxidase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[145]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[146]  R. Estabrook,et al.  THE LIGHT REVERSIBLE CARBON MONOXIDE INHIBITION OF THE STEROID C21-HYDROXYLASE SYSTEM OF THE ADRENAL CORTEX. , 1963, Biochemische Zeitschrift.

[147]  T. Poulos,et al.  Intermediates in P450 catalysis , 2005, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[148]  E. Gillam,et al.  Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[149]  O. Gotoh,et al.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.

[150]  M. Waterman,et al.  Folding Requirements Are Different between Sterol 14α-Demethylase (CYP51) from Mycobacterium tuberculosis and Human or Fungal Orthologs* , 2001, The Journal of Biological Chemistry.

[151]  Y. Yoshida,et al.  Yeast cytochrome P-450 catalyzing lanosterol 14 alpha-demethylation. I. Purification and spectral properties. , 1984, The Journal of biological chemistry.

[152]  D. Nelson,et al.  Cytochrome P450 and the individuality of species. , 1999, Archives of biochemistry and biophysics.

[153]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[154]  M. Waterman,et al.  Structural Diversities of Active Site in Clinical Azole-bound Forms between Sterol 14α-Demethylases (CYP51s) from Human and Mycobacterium tuberculosis* , 2005, Journal of Biological Chemistry.

[155]  T. Poulos,et al.  Redox control of the catalytic cycle of flavocytochrome P-450 BM3. , 1997, Biochemistry.

[156]  Eric F. Johnson,et al.  The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.

[157]  Charles J. Reedy,et al.  Heme protein assemblies. , 2004, Chemical reviews.

[158]  D. Kelly,et al.  Sterol 14alpha-demethylase activity in Streptomyces coelicolor A3(2) is associated with an unusual member of the CYP51 gene family. , 2002, The Biochemical journal.

[159]  N. Brown,et al.  Cloning and Functional Analysis of thepbr Lead Resistance Determinant of Ralstonia metallidurans CH34 , 2001, Journal of bacteriology.

[160]  H. Sticht,et al.  The structure of iron-sulfur proteins. , 1998, Progress in biophysics and molecular biology.

[161]  J. Dawson,et al.  Spectroscopic investigations of ferric cytochrome P-450-CAM ligand complexes. Identification of the ligand trans to cysteinate in the native enzyme. , 1982, The Journal of biological chemistry.

[162]  A. Munro,et al.  Roles of key active-site residues in flavocytochrome P450 BM3. , 1999, The Biochemical journal.

[163]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[164]  J. Lipscomb,et al.  The role of putidaredoxin and P450 cam in methylene hydroxylation. , 1972, The Journal of biological chemistry.

[165]  T. Ost,et al.  Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3. , 2001, Biochemistry.

[166]  T. Kimura,et al.  Studies on adrenal steroid hydroxylases. Oxidation-reduction properties of adrenal iron-sulfur protein (adrenodoxin). , 1973, Biochemistry.

[167]  E. Margoliash,et al.  Multiple low spin forms of the cytochrome c ferrihemochrome. EPR spectra of various eukaryotic and prokaryotic cytochromes c. , 1977, The Journal of biological chemistry.

[168]  F. Guengerich,et al.  Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein. , 1997, Protein expression and purification.

[169]  T. Shimada,et al.  Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[170]  S T Cole,et al.  Learning from the genome sequence of Mycobacterium tuberculosis H37Rv , 1999, FEBS letters.

[171]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[172]  B. Sclavi,et al.  Mycobacterium tuberculosis Rv1395 Is a Class III Transcriptional Regulator of the AraC Family Involved in Cytochrome P450 Regulation* , 2003, Journal of Biological Chemistry.

[173]  K. Inouye,et al.  Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. , 2000, Archives of biochemistry and biophysics.

[174]  Christopher M. Sassetti,et al.  Genetic requirements for mycobacterial survival during infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[175]  P. Ortiz de Montellano,et al.  Reversible pressure deformation of a thermophilic cytochrome P450 enzyme (CYP119) and its active-site mutants. , 2001, Journal of the American Chemical Society.

[176]  M. Youdim,et al.  Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness , 2006, British journal of pharmacology.

[177]  G. Babcock,et al.  Coordination geometries and vibrational properties of cytochromes alpha and alpha 3 in cytochrome oxidase from Soret excitation Raman spectroscopy. , 1981, Biochemistry.

[178]  Tommy B Andersson,et al.  An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates. , 2004, Drug Metabolism And Disposition.

[179]  F. Solano,et al.  Polyphenol Oxidase Activity Expression in Ralstonia solanacearum , 2005, Applied and Environmental Microbiology.

[180]  D. Sem,et al.  Interaction with arginine 597 of NADPH-cytochrome P-450 oxidoreductase is a primary source of the uniform binding energy used to discriminate between NADPH and NADH. , 1993, Biochemistry.

[181]  S. Kelly,et al.  Fluconazole tolerance in clinical isolates of Cryptococcus neoformans , 1997, Antimicrobial agents and chemotherapy.

[182]  M. J. Coon,et al.  Cytochrome P-450 : multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms , 1991 .

[183]  F. Guengerich,et al.  Characterization of a fusion protein between human cytochrome P450 1A1 and rat NADPH-P450 oxidoreductase in Escherichia coli. , 1997, Biochemical and biophysical research communications.

[184]  R. Ankumah,et al.  Enhanced Degradation of S-EthylN,N-Dipropylcarbamothioate in Soil and by an Isolated Soil Microorganism , 1990 .

[185]  M. Mergeay,et al.  Ralstonia metallidurans, a bacterium specifically adapted to toxic metals: towards a catalogue of metal-responsive genes. , 2003, FEMS microbiology reviews.

[186]  M. Adams,et al.  Spectroscopic characterization of the novel iron-sulfur cluster in Pyrococcus furiosus ferredoxin. , 1990, The Journal of biological chemistry.

[187]  N. C. Price,et al.  Analysis of the structural stability of the multidomain enzyme flavocytochrome P-450 BM3. , 1996, Biochimica et biophysica acta.

[188]  S. Martinis,et al.  Probing the heme iron coordination structure of pressure-induced cytochrome P420cam. , 1996, Biochemistry.

[189]  J. Lipscomb,et al.  Cytochrome aa3 from Nitrosomonas europaea. , 1986, The Journal of biological chemistry.

[190]  A. Rettie,et al.  Rabbit CYP4B1 engineered for high-level expression in Escherichia coli: ligand stabilization and processing of the N-terminus and heme prosthetic group. , 2003, Archives of biochemistry and biophysics.

[191]  Clive R. Bagshaw,et al.  Dynamics of actomyosin interactions in relation to the cross-bridge cycle. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[192]  Satoshi Takahashi,et al.  Dioxygen reduction by bo-type quinol oxidase from Escherichia coli studied by submillisecond-resolved freeze-quench EPR spectroscopy. , 2004, Biochemistry.

[193]  J. Dawson,et al.  Novel reactivity of cytochrome P-450-CAM. Methyl hydroxylation of 5,5-difluorocamphor. , 1984, The Journal of biological chemistry.

[194]  J. Boucher,et al.  Dehydration of alkyl- and arylaldoximes as a new cytochrome P450-catalyzed reaction: mechanism and stereochemical characteristics. , 1994, Biochemistry.

[195]  T. Ost,et al.  Protein engineering of cytochromes P-450. , 2000, Biochimica et biophysica acta.

[196]  S. Martinis,et al.  Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. , 1991, Biochemistry.

[197]  B. Møller,et al.  Plant cytochromes P450: tools for pharmacology, plant protection and phytoremediation. , 2003, Current opinion in biotechnology.

[198]  J. Lasker,et al.  Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. , 1996, Archives of biochemistry and biophysics.

[199]  T. Spiro,et al.  Metalloporphyrin core size resonance Raman marker bands revisited: implications for the interpretation of hemoglobin photoproduct Raman frequencies , 1987 .

[200]  B. Berks,et al.  Novel heme ligation in a c-type cytochrome involved in thiosulfate oxidation: EPR and MCD of SoxAX from Rhodovulum sulfidophilum. , 2001, Biochemistry.

[201]  L. Narhi,et al.  Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. , 1987, The Journal of biological chemistry.

[202]  N. Fujiwara,et al.  Characterization of the ybdT gene product of Bacillus subtilis: Novel fatty acid β-hydroxylating cytochrome P450 , 1999, Lipids.

[203]  I. Smith,et al.  Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence , 2003, Clinical Microbiology Reviews.

[204]  R. Herbrecht,et al.  Clinical pharmacokinetics of voriconazole. , 2006, International journal of antimicrobial agents.

[205]  N. Scrutton,et al.  Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. , 2003, Biochemistry.

[206]  J. S. Wang,et al.  Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[207]  A. Munro,et al.  The genome sequence of Mycobacterium tuberculosis reveals cytochromes P450 as novel anti-TB drug targets , 2000 .

[208]  H. Ogura,et al.  Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450. , 2001, Archives of biochemistry and biophysics.

[209]  K. R. Marshall,et al.  Thermodynamic and kinetic analysis of the isolated FAD domain of rat neuronal nitric oxide synthase altered in the region of the FAD shielding residue Phe1395. , 2004, European journal of biochemistry.

[210]  R. Coker,et al.  Review: Multidrug‐resistant tuberculosis: public health challenges , 2004, Tropical medicine & international health : TM & IH.

[211]  J. Peterson,et al.  Single turnover kinetics of the reaction between oxycytochrome P-450cam and reduced putidaredoxin. , 1988, The Journal of biological chemistry.

[212]  J. Coggins,et al.  Probing electron transfer in flavocytochrome P-450 BM3 and its component domains. , 1996, European journal of biochemistry.

[213]  A. Rettie,et al.  Covalent heme binding to CYP4B1 via Glu310 and a carbocation porphyrin intermediate. , 2003, Biochemistry.

[214]  K. R. Marshall,et al.  Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions. , 2006, Biochemistry.

[215]  E. Obayashi,et al.  Enzymatic reaction of hydrogen peroxide-dependent peroxygenase cytochrome P450s: kinetic deuterium isotope effects and analyses by resonance Raman spectroscopy. , 2002, Biochemistry.

[216]  R. Clark,et al.  Characterization of iron binding in IscA, an ancient iron-sulphur cluster assembly protein. , 2004, The Biochemical journal.

[217]  R. Speight,et al.  Enantioselective epoxidation of linolenic acid catalysed by cytochrome P450(BM3) from Bacillus megaterium. , 2005, Organic & biomolecular chemistry.

[218]  R. Feyereisen,et al.  Functional interactions in cytochrome P450BM3. Evidence that NADP(H) binding controls redox potentials of the flavin cofactors. , 2000, Biochemistry.

[219]  K. R. Marshall,et al.  Flavocytochrome P450 BM3 Mutant A264E Undergoes Substrate-dependent Formation of a Novel Heme Iron Ligand Set* , 2004, Journal of Biological Chemistry.

[220]  F. Meinhardt,et al.  cis/trans Isomerase of Unsaturated Fatty Acids of Pseudomonas putida P8: Evidence for a Heme Protein of the Cytochrome c Type , 1999, Applied and Environmental Microbiology.

[221]  G. Maga,et al.  Eukaryotic DNA polymerases. , 2002, Annual review of biochemistry.

[222]  P. Ortiz de Montellano,et al.  Covalent attachment of the heme prosthetic group in the CYP4F cytochrome P450 family. , 2002, Biochemistry.

[223]  S. Orrenius,et al.  The nature of the reverse type I (modified type II) spectral change in liver microsomes. , 1972, Biochemistry.

[224]  P. Ortiz de Montellano,et al.  EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme. , 2004, Biochemistry.

[225]  D. Gibson,et al.  Aromatic hydrocarbon dioxygenases in environmental biotechnology. , 2000, Current opinion in biotechnology.

[226]  E. Kharasch,et al.  Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.

[227]  T. Ost,et al.  Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM3. , 2001, Biochemistry.

[228]  G. Schoofs,et al.  Degradation of the thiocarbamate herbicide EPTC (S-ethyl dipropylcarbamothioate) and biosafening by Rhodococcus sp. strain NI86/21 involve an inducible cytochrome P-450 system and aldehyde dehydrogenase , 1995, Journal of bacteriology.

[229]  J. Cruickshank,et al.  The hydration structure of guanidinium and thiocyanate ions: Implications for protein stability in aqueous solution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[230]  A. Munro,et al.  Bacterial cytochromes P‐450 , 1996, Molecular microbiology.

[231]  M. J. Coon,et al.  Highly purified detergent-solubilized NADPH-cytochrome P-450 reductase from phenobarbital-induced rat liver microsomes. , 1974, Biochemical and biophysical research communications.

[232]  R. Croteau,et al.  Molecular cloning and characterization of a cytochrome P450 taxoid 2alpha-hydroxylase involved in Taxol biosynthesis. , 2004, Archives of biochemistry and biophysics.

[233]  L. Wong,et al.  Catalytic reductive dehalogenation of hexachloroethane by molecular variants of cytochrome P450cam (CYP101). , 2000, European journal of biochemistry.

[234]  F. Berthou,et al.  Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes. , 1997, Mutation research.

[235]  C David Stout,et al.  Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.

[236]  D. Garfinkel.  Studies on pig liver microsomes I. Enzymic and pigment composition of different microsomal fractions. , 1958, Archives of biochemistry and biophysics.

[237]  R. Edwards,et al.  Nitrogen control in bacteria. , 1995, Microbiological reviews.

[238]  M. Budde,et al.  Selective Hydroxylation of Highly Branched Fatty Acids and their Derivatives by CYP102A1 from Bacillus megaterium , 2006, Chembiochem : a European journal of chemical biology.

[239]  K. Degtyarenko,et al.  Secondary structure and membrane topology of cytochrome P450s. , 1989, Archives of biochemistry and biophysics.

[240]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. , 1964, The Journal of biological chemistry.

[241]  K. R. Marshall,et al.  Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. , 2003, Biochemical Society transactions.

[242]  B. Hoffman,et al.  Evidence for N coordination to Fe in the [2Fe-2S] clusters of Thermus Rieske protein and phthalate dioxygenase from Pseudomonas. , 1985, The Journal of biological chemistry.

[243]  D. Kelly,et al.  A Novel Sterol 14α-Demethylase/Ferredoxin Fusion Protein (MCCYP51FX) from Methylococcus capsulatusRepresents a New Class of the Cytochrome P450 Superfamily* , 2002, The Journal of Biological Chemistry.

[244]  N. Turner,et al.  Identification of a New Class of Cytochrome P450 from a Rhodococcus sp , 2002, Journal of bacteriology.

[245]  A. Parret,et al.  A novel class of self-sufficient cytochrome P450 monooxygenases in prokaryotes. , 2002, Trends in microbiology.

[246]  A. S. St John,et al.  Characterization of a membrane-associated serine protease in Escherichia coli , 1987, Journal of bacteriology.

[247]  J. Dawson,et al.  The diverse spectroscopic properties of ferrous cytochrome P-450-CAM ligand complexes. , 1983, The Journal of biological chemistry.

[248]  Martha,et al.  Ligand Binding to Heme Proteins , 2001 .

[249]  A. Rettie,et al.  Expression, Purification, Biochemical Characterization, and Comparative Function of Human Cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 Allelic Isoforms , 2002, Journal of Pharmacology and Experimental Therapeutics.

[250]  R. Baxter,et al.  Characterisation of flavodoxin NADP+ oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli. , 1998, European journal of biochemistry.

[251]  J. S. Miles,et al.  Identification of charge-transfer transitions in the optical spectrum of low-spin ferric cytochrome P-450 Bacillus megaterium. , 1993, European journal of biochemistry.

[252]  Tokuji Kimura,et al.  Fe2S2 protein resonance Raman spectra revisited: structural variations among adrenodoxin, ferredoxin, and red paramagnetic protein , 1989 .

[253]  S. Lindskog.  Structure and mechanism of carbonic anhydrase. , 1997, Pharmacology & therapeutics.

[254]  H. Panek,et al.  A whole genome view of prokaryotic haem biosynthesis. , 2002, Microbiology.

[255]  P. Dutta,et al.  Resonance coherent anti-Stokes Raman scattering spectra of fluorescent biological chromophores: Vibrational evidence for hydrogen bonding of flavin to glucose oxidase and for rapid solvent exchange. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[256]  Brian C. Baldwin,et al.  The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity* , 1997, The Journal of Biological Chemistry.

[257]  M. J. Coon,et al.  Reductive beta-scission of the hydroperoxides of fatty acids and xenobiotics: role of alcohol-inducible cytochrome P-450. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[258]  P. Karplus,et al.  Structural prototypes for an extended family of flavoprotein reductases: Comparison of phthalate dioxygenase reductase with ferredoxin reductase and ferredoxin , 1993, Protein science : a publication of the Protein Society.

[259]  N. Scrutton,et al.  Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. , 2003, The Biochemical journal.

[260]  A. Munro,et al.  Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme. , 1998, Biochemical and biophysical research communications.

[261]  D. Werck-Reichhart,et al.  Cytochromes P450 for engineering herbicide tolerance. , 2000, Trends in plant science.

[262]  M. J. Coon,et al.  Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. , 1978, The Journal of biological chemistry.

[263]  John H. White,et al.  A Self-sufficient Cytochrome P450 with a Primary Structural Organization That Includes a Flavin Domain and a [2Fe-2S] Redox Center* , 2003, Journal of Biological Chemistry.

[264]  D. Nies,et al.  New genes involved in chromate resistance in Ralstonia metallidurans strain CH34 , 2004, Archives of Microbiology.

[265]  R. Friesner,et al.  Thermal equilibrium of high- and low-spin forms of cytochrome P450 BM-3: repositioning of the substrate? , 2005, Journal of the American Chemical Society.